ClinicalTrials.Veeva

Menu

Safety and Efficacy of Implantable Collamer Lens Versus Implantable Phakic Lens IPCL in Myopic Patients; A Comparative Study

A

Al-Azhar University

Status

Completed

Conditions

Myopia

Treatments

Procedure: Implantable Collamer Lens (ICL)
Procedure: Implantable Intraocular Lens (IPCL)

Study type

Interventional

Funder types

Other

Identifiers

NCT06058780
ICL vs IPCL

Details and patient eligibility

About

Phakic intraocular lenses (pIOL) have proven to be a great alternative to corneal refractive surgery in certain situations. They offer several advantages over corneal techniques, such as being suitable for high myopes and causing relatively fewer higher-order aberrations. In addition, pIOLs have been shown to provide better retinal image magnification and higher contrast sensitivity compared to laser in situ keratomileusis, regardless of whether the myopia is low or high.

Enrollment

200 patients

Sex

All

Ages

20 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • myopia of more than 6 diopter

Exclusion criteria

  • unstable refraction
  • unstable refraction

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups

Implantable Collamer Lens (ICL)
Active Comparator group
Treatment:
Procedure: Implantable Collamer Lens (ICL)
Implantable Intraocular Lens (IPCL)
Active Comparator group
Treatment:
Procedure: Implantable Intraocular Lens (IPCL)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems